Zhejiang Medicine: Zhejiang Medicine Co., Ltd. is a company mainly engaged in drug production and sales. The main products are tablets, capsules, oral liquids, injections, raw materials and so on. It is an important manufacturer of raw materials and preparations in China, and has become an important production base of vitamins, antibiotics resistant to drug-resistant bacteria and quinolones. The company's leading product, vitamin E, ranks first in China and third in the world. The company is one of the top three domestic levofloxacin companies. FED, a new coenzyme additive, ranks third in the world in production and sales, and is the only enterprise in China that adopts fermentation method. In addition, the company is the only manufacturer of benzofluorenol in China at present, and its monopoly position in the industry is very prominent. Xinchang Pharmaceutical Factory under the company is listed as a national biotin production base by China Feed Engineering Technology Research Center, and the production and sales of vitamin H and kitasamycin rank third in the world.
Tonghua dongbao: tonghua dongbao Pharmaceutical Co., Ltd. specializes in traditional Chinese and western medicines, biological products, plastic building materials, etc. It is a key high-tech enterprise of torch plan recognized by the Ministry of Science and Technology. The company's trademark "Dongbao" was recognized as a well-known trademark in China by the State Administration for Industry and Commerce. The company has a series of products represented by recombinant human insulin (trade name: Ganshulin), and its product "Ganshulin" fills the gap in China, making China a country that can produce recombinant human insulin and glargine after the United States and Denmark. In 2002, the research achievement of recombinant human insulin won the second prize of National Science and Technology Progress Award. The recombinant insulin industrialization project declared by 20 10 Company won the first prize of Jilin Federation of Industry and Commerce and the first prize of Tonghua City. Recombinant human insulin injection ganshulin 30R obtained famous brand products in Jilin Province.